Assignee
ASTELLAS PHARMA INC
JP·318 granted patents·234 pending applications·1,757 citations·filing 1999–2025
Top patents by PatentIndex Score
552 records- 0195US7772407B2C-glycoside derivatives and salts thereofASTELLAS PHARMA INC·Filed 2007·Granted Aug 10, 2010·40 cites·20 claims
- 0295US7728120B2EML4-ALK fusion geneASTELLAS PHARMA INC·Filed 2007·Granted Jun 1, 2010·23 cites·1 claims
- 0394US10556906B2Quinazoline compoundASTELLAS PHARMA INC·Filed 2019·Granted Feb 11, 2020·29 cites·12 claims
- 0494US7605131B2EML4-ALK fusion geneASTELLAS PHARMA INC·Filed 2008·Granted Oct 20, 2009·30 cites·4 claims
- 0594US7396665B2Method of producing FR901228ASTELLAS PHARMA INC·Filed 2001·Granted Jul 8, 2008·39 cites·4 claims
- 0693US11938133B2Stable pharmaceutical composition for oral administrationASTELLAS PHARMA INC·Filed 2023·Granted Mar 26, 2024·2 cites·23 claims
- 0793US11707451B2Pharmaceutical composition for modified releaseASTELLAS PHARMA INC·Filed 2020·Granted Jul 25, 2023·3 cites·6 claims
- 0893US7608280B2Method of producing FR901228ASTELLAS PHARMA INC·Filed 2008·Granted Oct 27, 2009·16 cites·7 claims
- 0993US7084164B2Triazole derivativeASTELLAS PHARMA INC·Filed 2005·Granted Aug 1, 2006·40 cites·7 claims
- 1093US6958339B2Pyrazole derivativeASTELLAS PHARMA INC·Filed 2001·Granted Oct 25, 2005·54 cites·15 claims
- 1192US11944620B2Stable pharmaceutical composition for oral administrationASTELLAS PHARMA INC·Filed 2023·Granted Apr 2, 2024·1 cites·18 claims
- 1292US11938132B2Stable pharmaceutical composition for oral administrationASTELLAS PHARMA INC·Filed 2023·Granted Mar 26, 2024·1 cites·23 claims
- 1392US11938131B2Stable pharmaceutical composition for oral administrationASTELLAS PHARMA INC·Filed 2023·Granted Mar 26, 2024·1 cites·7 claims
- 1492US11938130B2Stable pharmaceutical composition for oral administrationASTELLAS PHARMA INC·Filed 2023·Granted Mar 26, 2024·1 cites·7 claims
- 1592US11839689B2Formulations of enzalutamideASTELLAS PHARMA INC·Filed 2022·Granted Dec 12, 2023·2 cites·7 claims
- 1692US10842780B2Pharmaceutical composition for modified releaseASTELLAS PHARMA INC·Filed 2017·Granted Nov 24, 2020·6 cites·25 claims
- 1792US10786500B2Stable pharmaceutical composition for oral administrationASTELLAS PHARMA INC·Filed 2016·Granted Sep 29, 2020·7 cites·11 claims
- 1892US9487491B2Diamino heterocyclic carboxamide compoundASTELLAS PHARMA INC·Filed 2014·Granted Nov 8, 2016·28 cites·26 claims
- 1992US7879844B2Heterocyclic janus kinase 3 inhibitorsASTELLAS PHARMA INC·Filed 2006·Granted Feb 1, 2011·29 cites·21 claims
- 2092US7776897B2Triazole derivative or salt thereofASTELLAS PHARMA INC·Filed 2005·Granted Aug 17, 2010·43 cites·14 claims
- 2192US7678820B2Hetero compoundASTELLAS PHARMA INC·Filed 2008·Granted Mar 16, 2010·28 cites·12 claims
- 2292US7153524B2Method for improving adsorption of a drug from ethylene oxide derivativeASTELLAS PHARMA INC·Filed 2003·Granted Dec 26, 2006·53 cites·6 claims
- 2391US10517966B2Anti-human MUC1 antibody Fab fragmentASTELLAS PHARMA INC·Filed 2017·Granted Dec 31, 2019·5 cites·32 claims
- 2491US7964710B2EML4-ALK fusion geneASTELLAS PHARMA INC·Filed 2009·Granted Jun 21, 2011·7 cites·1 claims
- 2591US7919494B2Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compoundASTELLAS PHARMA INC·Filed 2009·Granted Apr 5, 2011·27 cites·13 claims
- 2691US7915261B2Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compoundASTELLAS PHARMA INC·Filed 2009·Granted Mar 29, 2011·28 cites·16 claims
- 2791US7611724B2Method of producing FR901228ASTELLAS PHARMA INC·Filed 2009·Granted Nov 3, 2009·13 cites·9 claims
- 2891US7449456B2Diaminopyrimidinecarboxamide derivativeASTELLAS PHARMA INC·Filed 2003·Granted Nov 11, 2008·58 cites·18 claims
- 2991US7285554B2Pyrazole derivativeASTELLAS PHARMA INC·Filed 2006·Granted Oct 23, 2007·19 cites·13 claims
- 3091US7255876B2Composition comprises sustained-release fine particles and manufacturing method thereofASTELLAS PHARMA INC·Filed 2002·Granted Aug 14, 2007·46 cites·20 claims
- 3191US7056883B2Therapeutic agent for soft tissue sarcomaASTELLAS PHARMA INC·Filed 2004·Granted Jun 6, 2006·53 cites·6 claims
- 3290US12077519B2Heteroaryl carboxamide compoundASTELLAS PHARMA INC·Filed 2023·Granted Sep 3, 2024·1 cites·14 claims
- 3390US11897954B2Anti-TSPAN8/anti-CD3 bispecific antibody and anti-TSPAN8 antibodyASTELLAS PHARMA INC·Filed 2021·Granted Feb 13, 2024·2 cites·20 claims
- 3490US7919495B2Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compoundASTELLAS PHARMA INC·Filed 2006·Granted Apr 5, 2011·23 cites·15 claims
- 3590US7465731B2HDAC inhibitorASTELLAS PHARMA INC·Filed 2005·Granted Dec 16, 2008·18 cites·18 claims
- 3689US12502357B2Formulations of enzalutamideASTELLAS PHARMA INC·Filed 2024·Granted Dec 23, 2025·0 cites·1 claims
- 3789US10507251B2Anti-human MUC1 antibody fab fragmentASTELLAS PHARMA INC·Filed 2019·Granted Dec 17, 2019·3 cites·17 claims
- 3889US8716470B2Guanidine compoundASTELLAS PHARMA INC·Filed 2013·Granted May 6, 2014·12 cites·10 claims
- 3989US8012959B2Diaminopyrimidinecarboxamide derivativeASTELLAS PHARMA INC·Filed 2008·Granted Sep 6, 2011·20 cites·8 claims
- 4089US7056884B2Reduced FK228 and use thereofASTELLAS PHARMA INC·Filed 2001·Granted Jun 6, 2006·40 cites·6 claims
- 4188US10689393B2Tetrahydroisoquinoline derivativesASTELLAS PHARMA INC·Filed 2019·Granted Jun 23, 2020·3 cites·14 claims
- 4288US7968552B2Oxadiazolidinedione compoundASTELLAS PHARMA INC·Filed 2007·Granted Jun 28, 2011·9 cites·15 claims
- 4388US7951825B2Hetero compoundASTELLAS PHARMA INC·Filed 2010·Granted May 31, 2011·13 cites·3 claims
- 4488US2024117022A1Monoclonal antibodies against claudin-18 for treatment of cancerASTELLAS PHARMA INC·Filed 2023·Application pending·0 cites
- 4587US11679166B2Anti-human MUC1 antibody Fab fragmentASTELLAS PHARMA INC·Filed 2019·Granted Jun 20, 2023·2 cites·21 claims
- 4687US10888594B2Genetically engineered vaccinia virusesASTELLAS PHARMA INC·Filed 2017·Granted Jan 12, 2021·3 cites·25 claims
- 4787US10259821B2Tetrahydroisoquinoline derivativesASTELLAS PHARMA INC·Filed 2018·Granted Apr 16, 2019·3 cites·14 claims
- 4887US7709519B2Benzimidazolylidene propane-1,3 dione derivative or salt thereofASTELLAS PHARMA INC·Filed 2005·Granted May 4, 2010·13 cites·21 claims
- 4987US7342117B2α-form or β-form crystal of acetanilide derivativeASTELLAS PHARMA INC·Filed 2002·Granted Mar 11, 2008·28 cites·2 claims
- 5087US2024309108A1Antibodies against claudin 18.2 useful in cancer diagnosisASTELLAS PHARMA INC·Filed 2024·Application pending·0 cites
Showing the top 50 of 552 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ASTELLAS PHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →